Clinical samples from lung cancer patients have demonstrated the co-expression of CXCR4, p-STAT3, and VEGF-A, suggesting a potential role in tumor progression and angiogenesis in non-small cell lung cancer (NSCLC) [122]. This evidence concerns the gene STAT3 and lung cancer.